GB0301366D0 — A fixation device
Assigned to Glaxo Group Ltd · Expires 2003-02-19 · 23y expired
What this patent protects
A fixation device for fixing together two parts of a multi-part assembly that has a ring-like body which is movable from a manufactured state, in which the body is manufactured with an endless angular extent and a weakened zone therein, and a use state, in which the ring-like bod…
USPTO Abstract
A fixation device for fixing together two parts of a multi-part assembly that has a ring-like body which is movable from a manufactured state, in which the body is manufactured with an endless angular extent and a weakened zone therein, and a use state, in which the ring-like body is split at the weakened zone is disclosed.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.